International agreement to eliminate customs duties on approved pharmaceuticals

EU Member States adopted an international agreement to eliminate customs dutieson all new pharmaceuticals traded with the US and Switzerland. The agreement wasreached on 12 January 2007 and eliminates customs duties between the EU,Switzerland and US on finished pharmaceutical products and on the chemicalintermediates used in their production. It replaces a previous agreement from1994 that already enabled many pharmaceuticals to benefit from zero-tariffs, butdid not cover any of the more recent products. With this review, 1,290additional products have been added to the 7,329 products currently benefitingfrom duty-free treatment. The EU imports more than 80% of its pharmaceuticalsfrom the US and Switzerland, and the European Chemical Industry Council (CEFIC)believes that the agreement could save European pharmaceutical companies up to€230 million in 2007 alone.
Other articles
KŠB Announces Senior Appointments: Ivo Průša Named Partner; Dana Jacková, Jana Guričová and Ján Béreš Promoted to Counsel
Kocián Šolc Balaštík (KŠB) has recently made several senior appointments within its leadership team. Ivo Průša has been named Partner as of 1 January 2026, while Dana Jacková, Jana Guričová and Ján Béreš have been promoted to the position of Counsel.
KŠB Assisted with the Refinancing of the BigBoard Group, a leading player in the premium outdoor advertising market
Our team provided legal advice to BigBoard Praha, a leading player in the premium outdoor advertising market in the Czech Republic, in connection with its refinancing. Founded in 1993, the BigBoard Group is the largest provider of premium outdoor advertising in the Czech Republic, with an approximately 70% market share and annual turnover of around CZK 2 billion. Its advertising media cover key locations across the country, including the Prague metro and major transport hubs.
KŠB Assisted Sandberg Capital with a Majority Investment in HotelTime Solutions
The KŠB team provided legal advice to the investment group Sandberg Capital on the completion of a majority investment in HotelTime Solutions, one of the leading providers of cloud-based software for hotel operations management.